Skip to content
Haemokinesis logo — When every second counts.

Haemokinesis

When every second counts.

Founded 2011 Australia Hallam, Australia 34 employees Biotechnology, Health Care +1

General Information

Company Name Haemokinesis
Founded Year 2011
Location Australia Hallam, Australia
Employees 34
Industries Biotechnology, Health Care, Medical Devices
Social

BounceWatch is an independent company data service, not affiliated with Haemokinesis. To contact Haemokinesis, visit haemokinesis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Haemokinesis compare?

A PDF of Haemokinesis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Haemokinesis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Haemokinesis

Haemokinesis is an innovative biotechnology startup founded in 2010 in Australia with the slogan "When every second counts." The company specializes in delivering advanced blood diagnostic and testing technology for point-of-care (POC) and point-of-trauma (POT) blood diagnostics. Haemokinesis aims to address the limitations of existing human blood group testing in hospitals and blood banks by providing safe, fast, accurate, and reliable solutions. The company is committed to improving patient outcomes and saving lives by simplifying in-vitro diagnostic testing for medical professionals.

Haemokinesis is focused on removing the barriers of access to basic healthcare elements worldwide, with a specific emphasis on blood group testing and emergency medicine. The company's vision is to ensure that vital diagnostic technology is accessible to anyone, anywhere. With a focus on biotechnology and healthcare, Haemokinesis represents a promising investment opportunity in the field of medical technology and diagnostics. #EverySecondCounts #Haemokinesis #R&D #Immunohaematology

Business keywords: R&D, Immunohaematology, Point-of-Care Testing, Blood Diagnostics, Emergency Medicine, Medical Technology, Healthcare Innovation

No funding data available for Haemokinesis yet.

Haemokinesis Alternatives & Competitors

View All Alternatives
Haemokinesis vs

Pioneering precision in diagnostics with timely, actionable solutions for better healthcare outcomes...

Private Equity
51-200 employees
Biotechnology, Health Care
Haemokinesis vs
CorDx
CorDx United States

A global diagnostics organization delivering answers when you need them most.

100 employees
Health Care, Medical Devices
Haemokinesis vs
Paratus Diagnostics
Paratus Diagnostics United States

Advancing Diagnostic Technology

Venture round
3 employees
Biotechnology, Health Care

FAQ About Haemokinesis

When every second counts.
Haemokinesis was founded in 2011.
Haemokinesis is headquartered in Hallam, Australia.
Haemokinesis operates in Biotechnology, Health Care and Medical Devices. Its work centres on R&D, Immunohaematology, Point-of-Care Testing and Blood Diagnostics.
Haemokinesis has approximately 34 employees.
Top alternatives and competitors to Haemokinesis include Rivaara Labs, CorDx, Paratus Diagnostics, Ativa, Sight Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Haemokinesis and Rivaara Labs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Haemokinesis, https://bouncewatch.com/company/haemokinesis, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout